HER2 positive breast cancer

被引：0
|
作者：
Gianni, Luca
Bianchini, Giampaolo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-ED11-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ED11-2
引用
收藏
页数：2
相关论文
共 50 条
  • [1] IMMUNOTHERAPY FOR HER2 POSITIVE BREAST CANCER
    Vaidya, T. R.
    Ait-Oudhia, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S20 - S20
  • [2] Her2 positive breast cancer: practices
    Campone, Mario
    Berton-Rigaud, Dominique
    Bourbouloux, Emmanuelle
    Sophie, Sadot
    Zanetti, Alain
    Frenel, Jean-Sebastien
    [J]. BULLETIN DU CANCER, 2011, 98 (02) : 154 - 163
  • [3] Delayed breast cancer surgery in HER2 positive breast cancer
    Hur, Ho
    Le, Amy
    Chang, Helena R.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [4] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [5] Personalized medicine for HER2 positive breast cancer
    Tamura, Kenji
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [6] Delayed chemotherapy in HER2 positive breast cancer
    Hur, Ho
    Le, Amy
    Chang, Helena R.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [7] HER2 POSITIVE BREAST CANCER - BIOLOGY AND RESISTANCE
    Penault-Llorca, Frederique
    [J]. BREAST, 2019, 48 : S31 - S31
  • [8] Treatment of HER2 positive breast cancer patients
    Matos, Erika
    [J]. ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (03): : 236 - 245
  • [9] Adjuvant therapy in breast cancer HER2 positive
    Olivito, V.
    De Simone, R.
    La Gattuta, G.
    Lucia, M.
    Dima, G.
    Talarico, R.
    Filippelli, G.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII146 - VII146
  • [10] EARLY RELAPSE OF HER2 POSITIVE BREAST CANCER
    Zelen, Teodora Brdar
    Prica, Anja
    Jovisevic, Marija
    [J]. BREAST, 2023, 71 : S58 - S58
12345